Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery
Top Cited Papers
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (18), 1305-1310
- https://doi.org/10.1056/nejmoa011099
Abstract
Despite thromboprophylaxis, major knee surgery carries a high risk of venous thromboembolism. Fondaparinux, the first of a new class of synthetic antithrombotic agents, may reduce this risk.Keywords
This publication has 14 references indexed in Scilit:
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 2001
- Cannabis Arteritis RevisitedAngiology, 2001
- Prevention of Venous ThromboembolismChest, 2001
- Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty PatientsArchives of Internal Medicine, 2000
- Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393The Lancet, 1996
- The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic AntithromboticsAngewandte Chemie-International Edition, 1993
- Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED InvestigatorsJAMA, 1990
- The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activityThrombosis Research, 1988
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972